Table 53Annual probability of infection with intermittent pathogen
Study | Intermittent pathogen | Strategy 1 (new) probability | Strategy 2 (old) probability |
---|---|---|---|
Cohorts by pathogen | |||
Federiksen 1999 | PA | 22.5% | 33.3% |
France 2008 | BCC | 16.3% | 4.0% |
Lee 2004 | PA | 34.5% (30%)a | 26.2% (28%)a |
Whitford 1995b | BCC | 2.1% | 9.0% |
Protective equipment | |||
Chen 2001 | BCC | 0.9% | 8.8% |
Savant 2014c | PA | 36% | 46% |
Single inpatient room versus ward bed | |||
Chen 2001 | BCC | 7.0% | 15.0% |
France 2008 | BCC | 2.9% | 16.3% |
Incomplete cohort segregation including en suite bathroom facilities versus no cohort segregation | |||
Jones 2005d | PA | 0.0% | 9.7% |
BCC, B cepacia complex; PA, P aeruginosa
- (a)
Prevalence data (incidence data) 1990 versus 2000
- (b)
6 month probability translated into a 12 month probability using rates
- (c)
Prevalence data as incidence data not calculable
- (d)
2000 data compared to 2001 data as these are the dates when incidence is reported, the clinical evidence review compared 1999 to 2001 based on prevalence
- Table 53, Annual probability of infection with intermittent pathogen - Cystic Fi...Table 53, Annual probability of infection with intermittent pathogen - Cystic Fibrosis
- Nucleotide Links for GEO Profiles (Select 93749463) (8)Nucleotide
- PMC Links for GEO Profiles (Select 93749463) (194)PMC
Your browsing activity is empty.
Activity recording is turned off.
See more...